269 related articles for article (PubMed ID: 29112657)
1. Placental Complications Associated With Psychostimulant Use in Pregnancy.
Cohen JM; Hernández-Díaz S; Bateman BT; Park Y; Desai RJ; Gray KJ; Patorno E; Mogun H; Huybrechts KF
Obstet Gynecol; 2017 Dec; 130(6):1192-1201. PubMed ID: 29112657
[TBL] [Abstract][Full Text] [Related]
2. Adverse Gestational Outcomes Associated With Attention-Deficit/Hyperactivity Disorder Medication Exposure During Pregnancy.
Andrade C
J Clin Psychiatry; 2018; 79(1):. PubMed ID: 29505179
[TBL] [Abstract][Full Text] [Related]
3. Prescription Stimulant Use During Pregnancy and Risk of Neurodevelopmental Disorders in Children.
Suarez EA; Bateman BT; Hernandez-Diaz S; Straub L; McDougle CJ; Wisner KL; Gray KJ; Pennell PB; Lester B; Zhu Y; Mogun H; Huybrechts KF
JAMA Psychiatry; 2024 May; 81(5):477-488. PubMed ID: 38265792
[TBL] [Abstract][Full Text] [Related]
4. Anticonvulsant Mood Stabilizer and Lithium Use and Risk of Adverse Pregnancy Outcomes.
Cohen JM; Huybrechts KF; Patorno E; Desai RJ; Mogun H; Bateman BT; Hernández-Díaz S
J Clin Psychiatry; 2019 Jun; 80(4):. PubMed ID: 31237992
[TBL] [Abstract][Full Text] [Related]
5. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
[TBL] [Abstract][Full Text] [Related]
6. Associations of preterm birth, small-for-gestational age, preeclampsia and placental abruption with attention-deficit/hyperactivity disorder in the offspring: Nationwide cohort and sibling-controlled studies.
Beer RJ; Cnattingius S; Susser ES; Villamor E
Acta Paediatr; 2022 Aug; 111(8):1546-1555. PubMed ID: 35485179
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of one-year pharmacological treatment of adult attention-deficit/hyperactivity disorder (ADHD): an open-label prospective study of time in treatment, dose, side-effects and comorbidity.
Fredriksen M; Dahl AA; Martinsen EW; Klungsøyr O; Haavik J; Peleikis DE
Eur Neuropsychopharmacol; 2014 Dec; 24(12):1873-84. PubMed ID: 25453480
[TBL] [Abstract][Full Text] [Related]
8. Perinatal Outcomes of Women Diagnosed with Attention-Deficit/Hyperactivity Disorder: An Australian Population-Based Cohort Study.
Poulton AS; Armstrong B; Nanan RK
CNS Drugs; 2018 Apr; 32(4):377-386. PubMed ID: 29557079
[TBL] [Abstract][Full Text] [Related]
9. Osmotic Release Oral System Methylphenidate Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Chinese Youth: 8-Week Comparative Efficacy and 1-Year Follow-Up.
Su Y; Yang L; Stein MA; Cao Q; Wang Y
J Child Adolesc Psychopharmacol; 2016 May; 26(4):362-71. PubMed ID: 26779845
[TBL] [Abstract][Full Text] [Related]
10. Association Between Methylphenidate and Amphetamine Use in Pregnancy and Risk of Congenital Malformations: A Cohort Study From the International Pregnancy Safety Study Consortium.
Huybrechts KF; Bröms G; Christensen LB; Einarsdóttir K; Engeland A; Furu K; Gissler M; Hernandez-Diaz S; Karlsson P; Karlstad Ø; Kieler H; Lahesmaa-Korpinen AM; Mogun H; Nørgaard M; Reutfors J; Sørensen HT; Zoega H; Bateman BT
JAMA Psychiatry; 2018 Feb; 75(2):167-175. PubMed ID: 29238795
[TBL] [Abstract][Full Text] [Related]
11. Ischemic Placental Disease, Preterm Delivery, and Their Association With Opioid Use During Pregnancy.
Esposito DB; Bateman B; Werler M; Straub L; Mogun H; Hernandez-Diaz S; Huybrechts K
Am J Epidemiol; 2022 Mar; 191(5):759-768. PubMed ID: 34165143
[TBL] [Abstract][Full Text] [Related]
12. Placental Abnormalities and Placenta-Related Complications Following
Kong F; Fu Y; Shi H; Li R; Zhao Y; Wang Y; Qiao J
Front Endocrinol (Lausanne); 2022; 13():924070. PubMed ID: 35846290
[TBL] [Abstract][Full Text] [Related]
13. Risk of infant mortality among twins in relation to placental abruption: contributions of preterm birth and restricted fetal growth.
Ananth CV; Smulian JC; Srinivas N; Getahun D; Salihu HM
Twin Res Hum Genet; 2005 Oct; 8(5):524-31. PubMed ID: 16212842
[TBL] [Abstract][Full Text] [Related]
14. Risk of placental dysfunction disorders after prior miscarriages: a population-based study.
Gunnarsdottir J; Stephansson O; Cnattingius S; Akerud H; Wikström AK
Am J Obstet Gynecol; 2014 Jul; 211(1):34.e1-8. PubMed ID: 24495667
[TBL] [Abstract][Full Text] [Related]
15. Priapism associated with the use of stimulant medications and atomoxetine for attention-deficit/hyperactivity disorder in children.
Eiland LS; Bell EA; Erramouspe J
Ann Pharmacother; 2014 Oct; 48(10):1350-5. PubMed ID: 24982313
[TBL] [Abstract][Full Text] [Related]
16. Ischemic placental disease: epidemiology and risk factors.
Ananth CV; Vintzileos AM
Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):77-82. PubMed ID: 21839575
[TBL] [Abstract][Full Text] [Related]
17. Placental abruption and subsequent risk of pre-eclampsia: a population-based case-control study.
Parker SE; Werler MM; Gissler M; Tikkanen M; Ananth CV
Paediatr Perinat Epidemiol; 2015 May; 29(3):211-9. PubMed ID: 25761509
[TBL] [Abstract][Full Text] [Related]
18. QTc prolongation after ADHD medication.
Snircova E; Marcincakova Husarova V; Ondrejka I; Hrtanek I; Farsky I; Nosalova G
Neuro Endocrinol Lett; 2018 Feb; 38(8):549-554. PubMed ID: 29504733
[TBL] [Abstract][Full Text] [Related]
19. Placental abruption and adverse perinatal outcomes.
Ananth CV; Berkowitz GS; Savitz DA; Lapinski RH
JAMA; 1999 Nov; 282(17):1646-51. PubMed ID: 10553791
[TBL] [Abstract][Full Text] [Related]
20. The role of confounding in the association between pregnancy complications and subsequent preterm birth: a cohort study.
Dunne J; Tessema GA; Pereira G
BJOG; 2022 May; 129(6):890-899. PubMed ID: 34773346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
